{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "wsmg:health-sciences/medicine/neurology/neuro-006",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:54:58.000Z",
    "modified": "2026-01-13T13:48:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "quality-agent"
    ],
    "confidence": 0.96,
    "status": "validated",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/neurology",
    "subdomain": "epilepsy",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "isNativeDomain": true,
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Status Epilepticus",
    "summary": "Status epilepticus (SE) is a life-threatening neurological emergency defined as a seizure lasting >5 minutes or multiple seizures without recovery between. It requires immediate treatment with benzodiazepines followed by second-line agents and consideration of anesthetic agents for refractory cases.",
    "key_points": [
      "Definition: Seizure >5 min OR â‰¥2 seizures without return to baseline (operational)",
      "Traditional definition: >30 min; neuronal injury begins at 30-60 min",
      "First-line: IV lorazepam 4mg or IM midazolam 10mg (if no IV access)",
      "Second-line: IV fosphenytoin, levetiracetam, or valproate",
      "Refractory SE: Continuous seizures despite two AEDs; requires anesthetic infusion",
      "Mortality 20-30% in adults; higher with prolonged duration and older age"
    ],
    "statement": "Status epilepticus is a seizure lasting beyond 5 minutes requiring emergent benzodiazepine treatment, second-line antiepileptic drugs, and consideration of anesthetic agents for refractory cases to prevent permanent neurological injury.",
    "explanation": {
      "intuition": "Think of status epilepticus as a brain 'electrical fire' that, unlike normal seizures, doesn't self-extinguish. The longer it burns, the more permanent damage occurs. First responders use benzodiazepines as a 'fire extinguisher,' but if that doesn't work, progressively stronger agents are needed to stop the fire before irreversible brain injury occurs.",
      "key_insight": "TIME IS BRAIN in status epilepticus. The 5-minute operational definition exists because benzodiazepines become less effective as seizures continue (GABA receptor internalization), and neuronal injury accelerates after 30 minutes. The treatment protocol should be memorized and executed rapidly.",
      "technical_details": "With prolonged seizures, GABA-A receptors internalize, reducing benzodiazepine efficacy. NMDA receptors move to the surface, increasing excitotoxicity. Systemic complications include hyperthermia, rhabdomyolysis, acidosis, pulmonary edema. EEG monitoring is essential to detect non-convulsive SE and confirm seizure termination."
    },
    "definitions_glossary": {
      "status_epilepticus": "Seizure lasting >5 minutes or repeated seizures without recovery between",
      "convulsive_SE": "Generalized tonic-clonic seizure activity lasting >5 minutes",
      "non_convulsive_SE": "Subtle or electrographic seizures without convulsions; altered consciousness",
      "refractory_SE": "Seizures continuing after adequate doses of first and second-line agents",
      "super_refractory_SE": "Seizures continuing >24 hours after anesthetic initiation including recurrence",
      "benzodiazepine": "First-line agents (lorazepam, midazolam, diazepam) enhancing GABA-A inhibition",
      "fosphenytoin": "Prodrug of phenytoin; sodium channel blocker; second-line agent",
      "burst_suppression": "EEG pattern goal for anesthetic treatment of refractory SE",
      "GABA_A_receptor": "Inhibitory receptor targeted by benzodiazepines; internalizes with prolonged seizures",
      "NMDA_receptor": "Excitatory glutamate receptor; upregulates during prolonged seizures",
      "postictal_state": "Period of confusion/lethargy after seizure resolution",
      "Todd_paralysis": "Transient focal weakness after focal seizure"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Prolonged seizures cause GABA-A receptor internalization (reducing inhibition) and NMDA receptor upregulation (increasing excitation), creating a self-perpetuating loop and excitotoxic neuronal injury",
      "phases": {
        "early": "0-30 min: Compensated; BP/glucose elevated; benzodiazepines effective",
        "late": "30-60 min: Decompensation begins; hyperthermia, acidosis, hypotension",
        "prolonged": ">60 min: Irreversible neuronal injury; multi-organ failure"
      },
      "etiologies": {
        "acute_symptomatic": ["Stroke", "CNS infection", "Metabolic (hypoglycemia, hyponatremia)", "Drug toxicity/withdrawal"],
        "remote_symptomatic": ["History of prior brain injury", "Known epilepsy with breakthrough"],
        "febrile_SE": "Children with febrile SE (most benign prognosis)"
      }
    },
    "diagnostic_criteria": {
      "clinical_recognition": [
        "Continuous convulsive activity >5 minutes",
        "Repeated seizures without return to baseline consciousness",
        "Subtle SE: minimal motor activity but altered consciousness with EEG seizures"
      ],
      "workup": {
        "immediate": ["Fingerstick glucose", "IV access", "Vital signs monitoring"],
        "laboratory": ["BMP", "Calcium/magnesium", "AED levels if known epilepsy", "Toxicology screen"],
        "imaging": ["CT head to rule out structural cause (after stabilization)"],
        "EEG": ["Continuous monitoring to detect non-convulsive seizures and confirm termination"]
      }
    },
    "differential_diagnosis": [
      "Psychogenic non-epileptic seizures (PNES)",
      "Movement disorders (dystonia, chorea)",
      "Rigors from infection",
      "Decerebrate/decorticate posturing"
    ],
    "treatment_options": {
      "first_line": {
        "timing": "0-5 minutes",
        "medications": [
          {"drug": "Lorazepam", "dose": "0.1 mg/kg IV (max 4mg), repeat once"},
          {"drug": "Midazolam", "dose": "10mg IM (if no IV) or 0.2 mg/kg IN"},
          {"drug": "Diazepam", "dose": "10-20mg PR if no IV/IM access"}
        ],
        "efficacy": "~65% terminate seizures"
      },
      "second_line": {
        "timing": "5-20 minutes (if benzodiazepines fail)",
        "medications": [
          {"drug": "Fosphenytoin", "dose": "20 mg PE/kg IV at 150 mg PE/min"},
          {"drug": "Levetiracetam", "dose": "60 mg/kg IV (max 4500mg)"},
          {"drug": "Valproate", "dose": "40 mg/kg IV (max 3000mg)"}
        ],
        "choice": "ESETT trial showed equivalent efficacy"
      },
      "refractory_SE": {
        "timing": ">20 minutes (seizures continue despite two agents)",
        "options": [
          {"drug": "Midazolam infusion", "dose": "0.2 mg/kg bolus, then 0.1-2 mg/kg/hr"},
          {"drug": "Propofol", "dose": "2 mg/kg bolus, then 20-200 mcg/kg/min"},
          {"drug": "Pentobarbital", "dose": "5-15 mg/kg bolus, then 1-5 mg/kg/hr"}
        ],
        "goal": "Burst suppression on EEG for 24-48 hours"
      }
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Status Epilepticus"
    },
    "altLabel": [
      {"@language": "en", "@value": "SE"},
      {"@language": "en", "@value": "Prolonged seizure"},
      {"@language": "en", "@value": "Convulsive status epilepticus"}
    ],
    "definition": {
      "@language": "en",
      "@value": "A neurological emergency defined as a seizure lasting more than 5 minutes or repeated seizures without recovery, requiring urgent treatment to prevent permanent brain injury"
    },
    "notation": "neuro-006",
    "scopeNote": {
      "@language": "en",
      "@value": "Covers definition, pathophysiology, and stepwise treatment of status epilepticus"
    }
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/neurology/epilepsy",
        "skos:prefLabel": "Epilepsy"
      }
    ],
    "skos:narrower": [],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/neurology/neuro-007",
        "skos:prefLabel": "Epilepsy Classification"
      },
      {
        "@id": "wsmg:health-sciences/medicine/neurology/neuro-008",
        "skos:prefLabel": "Antiepileptic Drug Selection"
      }
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Status_epilepticus"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "27154005",
      "uri": "http://snomed.info/id/27154005",
      "description": "Status epilepticus"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "G41",
      "uri": "http://hl7.org/fhir/sid/icd-10-cm/G41",
      "description": "Status epilepticus"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D013226",
      "uri": "http://id.nlm.nih.gov/mesh/D013226",
      "description": "Status Epilepticus"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Define status epilepticus using operational (5 min) and traditional (30 min) criteria",
      "Execute stepwise treatment protocol: first-line, second-line, refractory",
      "Explain pathophysiology of benzodiazepine resistance with prolonged seizures",
      "Recognize non-convulsive status epilepticus and need for EEG",
      "Identify indications for continuous EEG monitoring and anesthetic infusions"
    ],
    "clinical_pearls": [
      "Benzodiazepine within 5 minutes: 65% response; after 30 min: much lower",
      "IM midazolam works as well as IV lorazepam if no IV access (RAMPART trial)",
      "ESETT trial: Fosphenytoin = Levetiracetam = Valproate for second-line",
      "Subtle SE: only eye deviation or nystagmus - EEG needed for diagnosis",
      "Super-refractory SE may require ketamine, immunotherapy, or ketogenic diet"
    ],
    "board_yield": "HIGH",
    "estimated_time": "25min",
    "target_audience": [
      "neurology_residents",
      "emergency_medicine_residents",
      "critical_care_fellows"
    ],
    "common_misconceptions": [
      "All convulsive activity is convulsive SE - may be PNES or movement disorder",
      "Benzodiazepines always work if given enough - efficacy decreases with time",
      "Seizure stops = patient is safe - need EEG to rule out non-convulsive SE"
    ]
  },
  "prerequisites": [
    {
      "@id": "wsmg:health-sciences/medicine/neurology/neuro-007",
      "skos:prefLabel": "Epilepsy Classification"
    }
  ],
  "related_concepts": [
    "benzodiazepines",
    "antiepileptic drugs",
    "EEG monitoring",
    "neurological emergency",
    "GABA receptors"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "Kapur J, Elm J, Chamberlain JM, et al.",
        "title": "ESETT Investigators. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus",
        "journal": "N Engl J Med",
        "year": 2019,
        "volume": "381",
        "pages": "2103-2113",
        "doi": "10.1056/NEJMoa1905795"
      }
    ],
    "confidence_rationale": "Based on ESETT trial and established treatment guidelines"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-13T13:48:00.000Z",
    "sources": [
      {
        "source": "AAN Guideline: Status Epilepticus in Adults. Neurology. 2016.",
        "type": "guideline",
        "year": 2016,
        "relevance": "Evidence-based SE management"
      },
      {
        "source": "Adams and Victor's Principles of Neurology, 11th ed. McGraw-Hill, 2019.",
        "type": "textbook",
        "year": 2019,
        "isbn": "978-0071842617",
        "relevance": "Comprehensive neurology reference"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.95,
    "completeness": 0.96,
    "accuracy": 0.97,
    "clarity": 0.94,
    "clinical_relevance": 0.98,
    "last_assessed": "2026-01-13T13:48:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Status_epilepticus",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q662860"
}